ABIONYX Pharma SA
EPA:ABNX.PA
Overview | Financials
Company Name | ABIONYX Pharma SA |
Symbol | ABNX.PA |
Currency | EUR |
Price | 1.348 |
Market Cap | 46,744,693 |
Dividend Yield | 0% |
52-week-range | 0.91 - 1.5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Sir Cyrille Tupin CPA |
Website | https://abionyx.com |
An error occurred while fetching data.
About ABIONYX Pharma SA
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD